Therapeutic Actions Gerson Therapy

NCBI pubmed

New Opportunities and Challenges to Defeat Cancer Stem Cells.

New Opportunities and Challenges to Defeat Cancer Stem Cells. Trends Cancer. 2017 Nov;3(11):780-796 Authors: Ramos EK, Hoffmann AD, Gerson SL, Liu H Abstract Cancer stem cells (CSCs) are a subpopulation of cancer cells that are capable of self-renewal, proliferation, differentiation, plastic adaptation, and immune regulation, thereby mediating tumorigenesis, metastasis, and therapy resistance. CSCs are associated with cancer progression and clinical outcome in cancer patients. Successful targeting of CSCs will therefore be necessary to eradicate and cure cancer. Functional regulators of stem cell (stemness) signaling pathways in human cancers have brought new opportunities to target CSCs and reframe cancer-targeting strategies in clinical settings. However, challenges remain due to a lack of complete understanding of CSC plasticity/heterogeneity and the limited efficacy of individual stemness inhibitors in cancer treatment. In this article we review CSC signaling pathways and the current state of CSC-targeting therapeutics in combinatory treatments in clinical trials. PMID: 29120754 [PubMed - in process]